EMMA · ISSUER CIK 822370
Emmaus Life Sciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Emmaus Life Sciences, Inc. insiders reported $18K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Lee Willis C (CEO, Director), with $18K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$18KInsider buying
$0.00Insider selling
+$18KNet open-market
Sep 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 202615:05 | Aug 31, 2026from May 30, 2025 | EMMA | CEO, Director | P · Buy | $0.03 | +530,767 | 690,167 | +333% | +$18K | +17.9% | +2.9% |